Archived story4 articles · 3 publishers
Personalised cancer vaccine cuts melanoma return risk in landmark trial
- Published
- Updated
- Reports
- 4 from 3 publishers
A world-first personalised cancer vaccine trial, led by a Sydney scientist, has dramatically reduced the risk of melanoma returning or patients dying from the disease. Researchers say the results could mark a turning point in cancer treatment and bring personalised medicine a step closer.
AI summary · Original reporting is linked alongside
Morning briefing · the United Kingdom · free
The 10 stories everyone is covering in the United Kingdom, in your inbox at 7 am your time.
grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗